GB9625968D0 - Vaccine - Google Patents
VaccineInfo
- Publication number
- GB9625968D0 GB9625968D0 GB9625968A GB9625968A GB9625968D0 GB 9625968 D0 GB9625968 D0 GB 9625968D0 GB 9625968 A GB9625968 A GB 9625968A GB 9625968 A GB9625968 A GB 9625968A GB 9625968 D0 GB9625968 D0 GB 9625968D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16761—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9625968A GB9625968D0 (en) | 1996-12-13 | 1996-12-13 | Vaccine |
EP19970947773 EP0946714A1 (en) | 1996-12-13 | 1997-12-10 | Recombinant equine herpesvirus type 1 (ehv-1) comprising a dysfunctional gene 71 region and use thereof as a vaccine |
PCT/GB1997/003327 WO1998026049A1 (en) | 1996-12-13 | 1997-12-10 | Recombinant equine herpesvirus type 1 (ehv-1) comprising a dysfunctional gene 71 region and use thereof as a vaccine |
JP52634398A JP2002512504A (en) | 1996-12-13 | 1997-12-10 | Recombinant equine herpesvirus type 1 (EHV-1) containing a dysfunctional 71 gene region and its use as a vaccine |
HU0002374A HUP0002374A3 (en) | 1996-12-13 | 1997-12-10 | Recombinant equine herpesvirus type 1 (ehv-1) comprising a dysfunctional gene 71 region and use thereof as a vaccine |
AU54018/98A AU738684B2 (en) | 1996-12-13 | 1997-12-10 | Recombinant equine herpesvirus type 1 (EHV-1) comprising a dysfunctional gene 71 region and use thereof as a vaccine |
CA 2274900 CA2274900A1 (en) | 1996-12-13 | 1997-12-10 | Recombinant equine herpesvirus type 1 (ehv-1) comprising a dysfunctional gene 71 region and use thereof as a vaccine |
US10/033,538 US20020155131A1 (en) | 1996-12-13 | 2001-10-19 | Recombinant equine herpesvirus type 1 (EHV-1) comprising a dysfunctional gene 71 region and use thereof as a vaccine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9625968A GB9625968D0 (en) | 1996-12-13 | 1996-12-13 | Vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9625968D0 true GB9625968D0 (en) | 1997-01-29 |
Family
ID=10804436
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9625968A Pending GB9625968D0 (en) | 1996-12-13 | 1996-12-13 | Vaccine |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0946714A1 (en) |
JP (1) | JP2002512504A (en) |
AU (1) | AU738684B2 (en) |
CA (1) | CA2274900A1 (en) |
GB (1) | GB9625968D0 (en) |
HU (1) | HUP0002374A3 (en) |
WO (1) | WO1998026049A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1129722A1 (en) | 2000-02-17 | 2001-09-05 | Boehringer Ingelheim Vetmedica Gmbh | gM-negative EHV-mutants |
AR040601A1 (en) | 2002-07-19 | 2005-04-13 | Boehringer Ingelheim Vetmed | GM NEGATIVE EHV MUTANTS WITHOUT HETEROLOGICAL ELEMENTS |
AU2003251356A1 (en) * | 2002-07-26 | 2004-02-16 | Animal Health Trust | Viral marker |
WO2013142371A1 (en) * | 2012-03-20 | 2013-09-26 | Merial Limited | Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein c and uses thereof |
-
1996
- 1996-12-13 GB GB9625968A patent/GB9625968D0/en active Pending
-
1997
- 1997-12-10 HU HU0002374A patent/HUP0002374A3/en unknown
- 1997-12-10 WO PCT/GB1997/003327 patent/WO1998026049A1/en not_active Application Discontinuation
- 1997-12-10 JP JP52634398A patent/JP2002512504A/en active Pending
- 1997-12-10 EP EP19970947773 patent/EP0946714A1/en not_active Ceased
- 1997-12-10 CA CA 2274900 patent/CA2274900A1/en not_active Abandoned
- 1997-12-10 AU AU54018/98A patent/AU738684B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
HUP0002374A2 (en) | 2000-11-28 |
CA2274900A1 (en) | 1998-06-18 |
JP2002512504A (en) | 2002-04-23 |
HUP0002374A3 (en) | 2001-12-28 |
WO1998026049A1 (en) | 1998-06-18 |
EP0946714A1 (en) | 1999-10-06 |
AU5401898A (en) | 1998-07-03 |
AU738684B2 (en) | 2001-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9904549A3 (en) | Vaccines | |
GB9712347D0 (en) | Vaccine | |
GB9718901D0 (en) | Vaccine | |
PL341698A1 (en) | Vaccine | |
GB9711990D0 (en) | Vaccine | |
GB9726555D0 (en) | Vaccine | |
GB9720585D0 (en) | Vaccine | |
EP0958373A4 (en) | Vaccines | |
PL331424A1 (en) | Antipaludian vaccine composition | |
GB9623233D0 (en) | Vaccine composition | |
ZA9711565B (en) | Vaccine | |
GB9625968D0 (en) | Vaccine | |
ZA982763B (en) | Vaccines | |
ZA957482B (en) | Vaccine | |
ZA973824B (en) | Vaccines | |
GB9419969D0 (en) | Vaccine | |
GB9625966D0 (en) | Vaccine | |
GB9625967D0 (en) | Vaccine | |
GB9606032D0 (en) | Vaccines | |
GB9605229D0 (en) | Vaccines | |
GB9626882D0 (en) | Vaccines | |
GB9602617D0 (en) | Vaccines | |
GB9614182D0 (en) | Vaccines | |
GB9604595D0 (en) | Vaccines | |
GB9604596D0 (en) | Vaccines |